← Back to Home

Bacterial Antiviral DNA-Synthesizing Enzyme Reveals Clues to Telomerase Evolution

DRT10 can produce repetitive DNA from an RNA template and, after modification, synthesize human telomere sequences in human cells. The finding connects the evolutionary histories of bacterial defense and chromosome protection and provides a starting point for new tools in telomere research.

By SURL BioNews

Telomeres at the ends of human chromosomes act as buffers that protect genetic information. Yet the origins of telomerase, which maintains these repetitive DNA sequences, may lie in mechanisms bacteria use to fend off viruses. A Columbia University research team found that the bacterial defense system DRT10 has DNA-synthesizing capabilities similar to those of telomerase and, after modification, can produce human telomere repeat sequences in human cells.

Columbia University Irving Medical Center announced the news on October 12, stating that the research had been published in *Nature*. A preprint the team previously released in 2025 documented DRT10's function and the modification experiments. Both versions belong to the same line of research, but the preprint is an earlier research record and cannot be treated directly as the full content of the published paper.

At the core of DRT10 is a reverse transcriptase, an enzyme that synthesizes DNA using RNA as a template. Early experiments showed that, for bacteria to use this system to resist bacteriophages, they must have a reverse transcriptase, a non-protein-coding RNA, and a protein called SLATT. The RNA provides a short template that the enzyme reads repeatedly, writing successive copies of the same sequence into longer repetitive DNA.

This repeated synthesis echoes the mechanism by which telomerase extends chromosome ends. The team combined phylogenetic analysis, structural comparisons, and functional experiments to support the inference that bacterial defense-associated reverse transcriptases and telomerase share an evolutionary origin. However, unresolved steps remain in how this capability entered early eukaryotes and was subsequently used to maintain linear chromosomes.

The research also translated these evolutionary clues into tests of a potential tool. According to the preprint, the team replaced DRT10's RNA template region with the corresponding sequence from human telomerase RNA and detected the synthesis of human telomere repeat DNA in HEK293T human cells. This demonstrates that the repeat sequences produced can be specified by modifying the template. However, producing telomere sequences inside cells remains a different experimental goal from attaching them to chromosome ends and restoring telomere function.

The university said the team hopes to explore diseases associated with defects in telomere maintenance and the possibility of keeping therapeutic T cells active, such as extending the duration of CAR-T cell activity. These applications remain research directions, with no evidence yet that DRT10 can repair patients' telomeres, slow cellular aging, or improve cancer treatment outcomes.

As the work moves from bacterial defense toward cell engineering, the key next step is determining whether DNA synthesis can be directed to the required locations and confirming cellular function and long-term safety. DRT10's clearest achievement so far is demonstrating a mechanism for repetitive DNA synthesis with a modifiable template. Whether it can become a tool for telomere repair will depend on overcoming the hurdles of targeting chromosome ends and validating function.

References

  1. Columbia University Irving Medical Center
  2. bioRxiv preprint via PubMed Central